cimetidine has been researched along with Fasciitis in 12 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Fasciitis: Inflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis (FASCIITIS, NECROTIZING), a serious fulminating infection (usually by a beta hemolytic streptococcus) causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The term fasciitis-panniculitis syndrome (FPS) is proposed as a novel compilation encompassing several disorders, common to which is subcutaneous induration caused by cicatrizing fasciitis as well as septal and lobular panniculitis and perimysial fibrosis." | 6.38 | The fasciitis-panniculitis syndrome: clinical spectrum and response to cimetidine. ( Boss, JH; Missellevitch, I; Naschitz, JE; Rosner, I; Shajrawi, I; Yeshurun, D; Zuckerman, E, 1992) |
| "Treatment with cimetidine caused the remission of cutaneous manifestations and the extracutaneous abnormalities, such as nailfold capillary disturbances and the presence of antithyroid antibodies, improved." | 5.28 | Treatment with cimetidine of atypical fasciitis panniculitis syndrome. ( Abrahamson, JE; Boss, JH; Misselevitch, I; Naschitz, JE; Rosner, I; Yeshurun, D, 1990) |
| "Eosinophilic fasciitis is a syndrome of imprecise classification which usually responds well to corticosteroids." | 5.27 | [Eosinophilic fasciitis. Response to treatment with cimetidine]. ( Betlloch Mas, I; Castells Rodellas, A; Jiménez Martínez, A; Jorda Cuevas, E; Ramón Quiles, D, 1987) |
| "Idiopathic FPS, that is, eosinophilic fasciitis, was diagnosed in 14 patients." | 2.39 | The fasciitis-panniculitis syndromes. Clinical and pathologic features. ( Boss, JH; Misselevich, I; Naschitz, JE; Rosner, I; Yeshurun, D, 1996) |
| "The term fasciitis-panniculitis syndrome (FPS) is proposed as a novel compilation encompassing several disorders, common to which is subcutaneous induration caused by cicatrizing fasciitis as well as septal and lobular panniculitis and perimysial fibrosis." | 2.38 | The fasciitis-panniculitis syndrome: clinical spectrum and response to cimetidine. ( Boss, JH; Missellevitch, I; Naschitz, JE; Rosner, I; Shajrawi, I; Yeshurun, D; Zuckerman, E, 1992) |
| "The histological features of lipodermatosclerosis and eosinophilic fasciitis and its variants were compared in a prospective study of outpatients attending the vascular clinic and inpatients in the Department of Medicine of a regional university hospital." | 1.29 | Pathogenesis of lipodermatosclerosis of venous disease: the lesson learned from eosinophilic fasciitis. ( Boss, JH; Croitoru, S; Misselevich, I; Naschitz, JE; Schwartz, H; Shajrawi, I; Yeshurun, D, 1993) |
| "Treatment with cimetidine caused the remission of cutaneous manifestations and the extracutaneous abnormalities, such as nailfold capillary disturbances and the presence of antithyroid antibodies, improved." | 1.28 | Treatment with cimetidine of atypical fasciitis panniculitis syndrome. ( Abrahamson, JE; Boss, JH; Misselevitch, I; Naschitz, JE; Rosner, I; Yeshurun, D, 1990) |
| "The long-term outcome of eosinophilic fasciitis (EF) described for the first time by Shulman in 1974 remains unclear." | 1.27 | [Long-term development of eosinophilic fasciitis. Study of 11 cases]. ( Blétry, O; Etienne, SD; Frances, C; Godeau, P; Herson, S; Le Thi Huong, Du; Mouthon, JM; Piette, JC; Wechsler, B, 1984) |
| "Eosinophilic fasciitis is a syndrome of imprecise classification which usually responds well to corticosteroids." | 1.27 | [Eosinophilic fasciitis. Response to treatment with cimetidine]. ( Betlloch Mas, I; Castells Rodellas, A; Jiménez Martínez, A; Jorda Cuevas, E; Ramón Quiles, D, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herson, S | 2 |
| Piette, JC | 1 |
| Frances, C | 1 |
| Etienne, SD | 1 |
| Le Thi Huong, Du | 1 |
| Mouthon, JM | 1 |
| Blétry, O | 1 |
| Wechsler, B | 1 |
| Godeau, P | 2 |
| García-Morteo, O | 1 |
| Maldonado-Cocco, JA | 1 |
| Barreira, JC | 1 |
| Barceló, HA | 1 |
| Loftin, EB | 1 |
| Laso, FJ | 1 |
| Pastor, I | 1 |
| de Castro, S | 1 |
| Solomon, G | 1 |
| Barland, P | 1 |
| Rifkin, H | 1 |
| Naschitz, JE | 5 |
| Yeshurun, D | 5 |
| Schwartz, H | 1 |
| Croitoru, S | 1 |
| Shajrawi, I | 2 |
| Misselevich, I | 2 |
| Boss, JH | 5 |
| Rosner, I | 3 |
| Zuckerman, E | 1 |
| Missellevitch, I | 1 |
| Misselevitch, I | 2 |
| Abrahamson, JE | 1 |
| Brechignac, S | 1 |
| Jiménez Martínez, A | 1 |
| Jorda Cuevas, E | 1 |
| Ramón Quiles, D | 1 |
| Betlloch Mas, I | 1 |
| Castells Rodellas, A | 1 |
2 reviews available for cimetidine and Fasciitis
| Article | Year |
|---|---|
The fasciitis-panniculitis syndromes. Clinical and pathologic features.
Topics: Adipose Tissue; Adrenal Cortex Hormones; Cimetidine; Diagnosis, Differential; Fasciitis; Histamine H | 1996 |
The fasciitis-panniculitis syndrome: clinical spectrum and response to cimetidine.
Topics: Cimetidine; Eosinophilia; Fasciitis; Humans; Panniculitis; Syndrome | 1992 |
10 other studies available for cimetidine and Fasciitis
| Article | Year |
|---|---|
[Long-term development of eosinophilic fasciitis. Study of 11 cases].
Topics: Adult; Aged; Cimetidine; Colchicine; Eosinophilia; Factor XIII; Fasciitis; Female; Humans; Male; Mid | 1984 |
Cimetidine and eosinophilic fasciitis.
Topics: Adult; Cimetidine; Eosinophilia; Fasciitis; Female; Humans; Middle Aged | 1984 |
Cimetidine and eosinophilic fasciitis.
Topics: Adult; Cimetidine; Eosinophilia; Fasciitis; Female; Guanidines; Humans | 1983 |
Cimetidine and eosinophilic fasciitis.
Topics: Cimetidine; Eosinophilia; Fasciitis; Female; Guanidines; Humans; Middle Aged | 1983 |
Eosinophilic fasciitis responsive to cimetidine.
Topics: Cimetidine; Eosinophilia; Fasciitis; Guanidines; Humans; Male; Middle Aged; Prednisone; Receptors, H | 1982 |
Pathogenesis of lipodermatosclerosis of venous disease: the lesson learned from eosinophilic fasciitis.
Topics: Adipose Tissue; Aged; Cimetidine; Collagen; Eosinophilia; Fascia; Fasciitis; Female; Fibrosis; Human | 1993 |
Downslope claudication in eosinophilic fasciitis: a fourth type of claudication--case presentations.
Topics: Aged; Cimetidine; Eosinophilia; Fasciitis; Female; Humans; Intermittent Claudication; Male | 1991 |
Treatment with cimetidine of atypical fasciitis panniculitis syndrome.
Topics: Adult; Aged; Cimetidine; Eosinophilia; Fasciitis; Female; Humans; Male; Middle Aged; Panniculitis; P | 1990 |
Cimetidine in eosinophilic fasciitis.
Topics: Adult; Cimetidine; Eosinophilia; Fasciitis; Female; Humans; Male; Middle Aged | 1990 |
[Eosinophilic fasciitis. Response to treatment with cimetidine].
Topics: Cimetidine; Eosinophilia; Fasciitis; Histamine Release; Humans; Male; Middle Aged; Prednisone | 1987 |